![Victoria Richon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Victoria Richon
Amministratore Delegato presso
Entact Bio, Inc.
Profilo
Victoria M.
Richon is the founder of Aton Pharma, Inc. Current positions include Chief Executive Officer & Director at Entact Bio, Inc. since 2022, Director at the American Association for Cancer Research since 1993, Director at HotSpot Therapeutics, Inc. since 2018, and Director at Auron Therapeutics, Inc. since 2023.
Former positions include President, Chief Executive Officer & Director at Ribon Therapeutics, Inc. from 2015 to 2022, Senior Director-Cancer Biology & Therapeutics at Merck Research Laboratories Massachusetts LLC, Independent Director at Epizyme, Inc. from 2019 to 2022, Vice President-Biological Sciences at Epizyme, Inc. from 2008 to 2012, and Principal at Sloan-Kettering Institute for Cancer Research.
Education includes a doctorate from the University of Nebraska Medical Center and an undergraduate degree from the University of Vermont.
Posizioni attive di Victoria Richon
| Società | Posizione | Inizio |
|---|---|---|
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Direttore/Membro del Consiglio | 01/01/1993 |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Direttore/Membro del Consiglio | 30/10/2018 |
Entact Bio, Inc.
 Entact Bio, Inc. BiotechnologyHealth Technology Develops medicines for increasing protein function | Amministratore Delegato | 01/07/2022 |
Auron Therapeutics, Inc.
 Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Direttore/Membro del Consiglio | 10/08/2023 |
Precedenti posizioni note di Victoria Richon
| Società | Posizione | Fine |
|---|---|---|
| EPIZYME, INC. | Direttore/Membro del Consiglio | 12/08/2022 |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops cacner therapies | Amministratore Delegato | 17/02/2022 |
| EPIZYME, INC. | Corporate Officer/Principal | 01/01/2012 |
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical therapeutics for cancer and other diseases | Fondatore | - |
Sloan-Kettering Institute for Cancer Research
 Sloan-Kettering Institute for Cancer Research Miscellaneous Commercial ServicesCommercial Services Part of Memorial Sloan Kettering Cancer Center, Sloan-Kettering Institute for Cancer Research is a company that operates in the Research & Development industry. The company is based in New York, NY. | Corporate Officer/Principal | - |
Formazione di Victoria Richon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
77
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical therapeutics for cancer and other diseases | Health Technology |
University of Nebraska Medical Center
 University of Nebraska Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Sloan-Kettering Institute for Cancer Research
Sloan-Kettering Institute for Cancer Research Miscellaneous Commercial ServicesCommercial Services Part of Memorial Sloan Kettering Cancer Center, Sloan-Kettering Institute for Cancer Research is a company that operates in the Research & Development industry. The company is based in New York, NY. | Commercial Services |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops cacner therapies | Health Technology |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Health Technology |
Auron Therapeutics, Inc.
Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Commercial Services |
Entact Bio, Inc.
Entact Bio, Inc. BiotechnologyHealth Technology Develops medicines for increasing protein function | Health Technology |
